| ATC Class | Antimicrobial | Number of prescriptions/1,000 inhabitants | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | |||
| Roman numerals I to III indicate the ranking of antimicrobials based on importance in human medicine as outlined by the Veterinary Drugs Directorate. ATC = Anatomical Therapeutic Chemical. NPD = No prescriptions dispensed |
||||||||||||
| I | Combinations of penicillins, including ß-lactamase inhibitors (J01CR) | Amoxicillin and enzyme inhibitor (J01CR02) | 18.66 | 18.41 | 17.54 | 17.69 | 16.98 | 18.66 | 19.35 | 19.67 | 20.54 | 21.02 |
| Third-generation cephalosporins (J01DD) | Cefixime (J01DD08) | 5.66 | 5.28 | 4.83 | 4.23 | 3.68 | 3.74 | 3.77 | 3.98 | 4.23 | 4.46 | |
| Fluoroquinolones (J01MA) | Ofloxacin (J01MA01) | 1.78 | 1.47 | 1.22 | 1.09 | 0.98 | 0.84 | 0.85 | 0.74 | 0.64 | 0.55 | |
| Ciprofloxacin (J01MA02) | 51.25 | 47.70 | 48.32 | 51.35 | 53.46 | 55.90 | 61.06 | 61.76 | 62.56 | 62.54 | ||
| Norfloxacin (J01MA06) | 12.49 | 12.06 | 11.43 | 10.71 | 10.06 | 9.30 | 8.83 | 7.58 | 6.96 | 6.42 | ||
| Levofloxacin (J01MA12) | 10.35 | 14.32 | 13.11 | 13.36 | 13.10 | 11.48 | 10.51 | 9.68 | 9.68 | 9.21 | ||
| Moxifloxacin (J01MA14) | 0.36 | 4.68 | 7.89 | 10.23 | 11.07 | 13.35 | 16.55 | 17.66 | 17.48 | 17.68 | ||
| Glycopeptides (J01XA) | Vancomycin (J01XA01) | 0.14 | 0.14 | 0.16 | 0.19 | 0.34 | 0.39 | 0.37 | 0.40 | 0.42 | 0.48 | |
| Imidazole (J01XD) | Metronidazole (J01XD01) | NPD | 16.65 | 16.71 | 17.09 | 17.25 | 17.41 | 18.50 | 17.70 | 18.06 | 18.60 | |
| Linezolid (J01XX) | Linezolid (J01XX08) | NPD | < 0.01 | 0.01 | 0.02 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.07 | |
| II | Penicillins with extended spectrum (J01CA) | Ampicillin (J01CA01) | 3.28 | 2.77 | 2.22 | 1.98 | 1.68 | 1.36 | 1.19 | 0.98 | 0.86 | 0.78 |
| Amoxicillin (J01CA04) | 179.87 | 172.09 | 162.04 | 162.10 | 149.79 | 163.86 | 165.55 | 155.76 | 154.31 | 156.66 | ||
| Pivampicillin (J01CA02) | 9.75 | 8.48 | 6.64 | 5.70 | 4.60 | 3.12 | 2.19 | 1.78 | 0.63 | 0.01 | ||
| ß-lactamase sensitive penicillins (J01CE) | Penicillin G (J01CE01) | 0.13 | 0.08 | 0.02 | 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | |
| Penicillin V (J01CE02) | 45.29 | 42.02 | 39.83 | 39.62 | 36.59 | 36.89 | 37.25 | 34.87 | 32.93 | 32.09 | ||
| ß-lactamase resistant penicillins (J01CF) | Cloxacillin (J01CF02) | 19.78 | 18.38 | 16.78 | 15.61 | 14.17 | 12.49 | 11.87 | 10.34 | 9.30 | 8.35 | |
| First-generation cephalosporins (J01DB) | Cephalexin (J01DB01) | 39.09 | 39.63 | 40.87 | 42.88 | 43.28 | 45.93 | 48.70 | 47.15 | 47.25 | 47.07 | |
| Cefadroxil (J01DB05) | 1.94 | 2.07 | 2.20 | 2.36 | 2.38 | 2.42 | 2.77 | 2.80 | 2.92 | 3.02 | ||
| Second-generation cephalosporins (J01DC) | Cefaclor (J01DC04) | 18.62 | 13.78 | 9.73 | 7.19 | 4.98 | 4.36 | 3.23 | 2.54 | 2.06 | 1.65 | |
| Cefprozil (J01DC10) | 14.59 | 16.47 | 18.50 | 21.20 | 22.98 | 23.82 | 23.44 | 20.01 | 18.95 | 18.53 | ||
| Cefuroxime axetil (J01DC02) | 21.89 | 18.71 | 14.83 | 13.03 | 11.40 | 11.47 | 10.73 | 10.10 | 9.76 | 9.55 | ||
| Combinations of sulfonamides and trimethoprim, including derivatives (J01EE) | Sulfamethoxazole and trimethoprim (J01EE01) | 56.27 | 50.43 | 44.41 | 40.95 | 37.07 | 35.14 | 35.45 | 33.67 | 33.57 | 33.11 | |
| Sulfadiazine and trimethoprim (J01EE02) | 0.25 | 0.20 | 0.15 | 0.11 | 0.05 | 0.01 | < 0.01 | NPD | < 0.01 | < 0.01 | ||
| Macrolides (J01FA) | Azithromycin (J01FA10) | 42.49 | 52.86 | 59.62 | 66.16 | 61.02 | 66.06 | 65.36 | 59.71 | 58.99 | 58.39 | |
| Clarithromycin (J01FA09) | 69.20 | 69.22 | 64.72 | 63.47 | 59.11 | 65.01 | 67.07 | 65.07 | 65.01 | 66.64 | ||
| Erythromycin (J01FA01) | 34.14 | 26.99 | 20.63 | 18.69 | 15.06 | 12.65 | 11.14 | 9.09 | 8.56 | 6.82 | ||
| Lincosamides J01FF) | Clindamycin (J01FF01) | 15.92 | 16.74 | 17.63 | 18.48 | 18.85 | 19.73 | 21.86 | 21.94 | 22.11 | 22.33 | |
| Aminoglycosides (J01GB) | Tobramycin (J01GB01) | NPD | NPD | NPD | NPD | NPD | NPD | 0.05 | 0.06 | 0.06 | 0.08 | |
| Other quinolones, excluding fluoroquinolones (J01MB) | Nalidixic acid (J01MB02) | 0.08 | 0.06 | 0.05 | 0.04 | 0.05 | < 0.01 | < 0.01 | < 0.01 | NPD | < 0.01 | |
| Sulfonamide combinations, excluding trimethoprim (J01RA) | Erythromycin-sulfisoxazole (J01RA02) | 3.50 | 2.43 | 1.58 | 1.05 | 0.67 | 0.60 | 0.52 | 0.36 | 0.12 | < 0.01 | |
| Steroid antimicrobials (J01XC) | Fusidic acid (J01XC01) | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | 0.07 | 0.05 | 0.04 | 0.02 | |
| III | Tetracyclines (J01AA) | Doxycycline (J01AA02) | 11.79 | 11.00 | 10.17 | 10.07 | 9.55 | 10.07 | 10.92 | 11.43 | 12.03 | 12.58 |
| Minocycline (J01AA08) | 16.76 | 16.90 | 17.01 | 17.23 | 17.11 | 16.97 | 17.45 | 16.49 | 16.34 | 16.17 | ||
| Tetracycline (J01AA07) | 14.91 | 13.23 | 12.08 | 11.07 | 10.01 | 9.26 | 8.66 | 7.61 | 7.14 | 6.88 | ||
| Amphenicols (J01BA) | Chloramphenicol (J01BA01) | < 0.01 | < 0.01 | < 0.01 | NPD | < 0.01 | < 0.01 | NPD | NPD | NPD | NPD | |
| Trimethoprim and derivatives (J01EA) | Trimethoprim (J01EA01) | 2.22 | 2.12 | 2.13 | 2.16 | 2.02 | 1.85 | 1.95 | 1.93 | 1.87 | 1.91 | |
| Short-acting sulfonamides (J01EB) | Sulfamethizole (J01EB02), sulfapyridine (J01EB04), sulfisoxazole (J01EB05) | 0.07 | 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | NPD | |
| Intermediate-acting sulfonamides (J01EC) | Sulfadiazine (J01EC02), sulfamethoxazole (J01EC04) | 0.02 | < 0.01 | < 0.01 | 0.01 | 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | |
| Nitrofuran derivatives (J01XE) | Nitrofurantoin (J01XE01) | 14.61 | 15.76 | 16.41 | 17.48 | 19.13 | 20.35 | 22.67 | 23.20 | 24.89 | 27.05 | |
| Fosfomycin (J01XX) | Fosfomycin (J01XX01) | 0.44 | 0.47 | 0.29 | 0.21 | 0.14 | 0.11 | 0.09 | 0.05 | 0.01 | 0.02 | |
| NC | Methenamine (J01XX) | Methenamine (J01XX05) | 0.27 | 0.28 | 0.29 | 0.28 | 0.25 | 0.23 | 0.23 | 0.23 | 0.16 | 0.24 |
| Total (J01) | 738.98 | 735.62 | 706.57 | 710.89 | 677.86 | 704.95 | 714.52 | 677.44 | 670.79 | 671.10 | ||